Diligence memo · auto-generated · as of July 2, 2026
Segmed, Inc.
Segmed, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Segmed, Inc. operates in Healthtech, based in PALO ALTO, CA, USA; Remote. Real-World Data for Health Innovation
Sub-sector tags: AI, Health Tech, Healthcare, healthtech.
Capital & rounds (filed)filed
Segmed, Inc. has raised $10M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $10M on 2022-10-24.
Most recent recorded round closed around 2022-10-24.
Valuation (modeled)modeled
Provath models Segmed, Inc. at approximately $95M (range $13M–$303M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.27× the median modeled value of Series A Healthtech companies in 2022–2024 (190 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 3.7 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 70% of Healthtech peers (2138 compared).
Modeled value ranks above 76% of those peers.
Closest niche peers: Nayya Health, Inc., Nue Life Health Inc., W Health Studio, Inc., Avant-garde Health, Inc., Kinetik Healthcare Solutions, Inc.
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.